CoreCivic Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:15 pm UTC| Business
NASHVILLE, Tenn., Nov. 08, 2017 -- CoreCivic, Inc. (NYSE:CXW) (the Company) announced today its financial results for the third quarter of 2017. Third Quarter 2017 Highlights Diluted EPS of $0.35Adjusted Diluted EPS...
Helius Medical Technologies to Report Results from Traumatic Brain Injury Clinical Trials
Nov 08, 2017 21:15 pm UTC| Business
NEWTOWN, Pa., Nov. 08, 2017 -- Helius Medical Technologies, Inc. (TSX:HSM), (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced today that it will report...
Farmer Bros. Co. to Present at the 2017 Southwest IDEAS Investor Conference
Nov 08, 2017 21:15 pm UTC| Business
NORTHLAKE, Texas, Nov. 08, 2017 -- Farmer Bros. Co. (NASDAQ:FARM) today announced that it will present at the 2017 Southwest IDEAS Investor Conference at the Westin Dallas Downtown Hotel in Dallas, Texas, on Wednesday,...
Chembio Diagnostics Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:15 pm UTC| Business
MEDFORD, N.Y., Nov. 08, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the third quarter ended September...
HC2 Holdings Reports Third Quarter 2017 Results
Nov 08, 2017 21:15 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- HC2 Holdings, Inc. (“HC2”) (NYSE:HCHC), a diversified holding company, announced today its consolidated results for the third quarter 2017, which ended on September 30, 2017. “We continue to...
Papa Murphy’s Holdings, Inc. Reports Third Quarter 2017 Results
Nov 08, 2017 21:13 pm UTC| Business
VANCOUVER, Wash., Nov. 08, 2017 -- Papa Murphy’s Holdings, Inc. (NASDAQ:FRSH) today announced financial results for its third quarter ended October 2, 2017. Key financial highlights for the third quarter of 2017...
Maiden Holdings, Ltd. Announces Third Quarter 2017 Financial Results
Nov 08, 2017 21:13 pm UTC| Business
Highlights for the quarter ended September 30, 2017 Net loss attributable to Maiden common shareholders of $63.6 million, or $0.74 per diluted common share compared with net income attributable to Maiden common...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update